Background The first COVID-19 vaccine outside a clinical trial setting was administered on
Dec 8, 2020. To ensure global vaccine equity, vaccine targets were set by the COVID-19 …

Background Evidence to date has shown that inequality in health, and vaccination coverage
in particular, can have ramifications to wider society. However, whilst individual studies …

Background: Vaccination is one of the most effective public health interventions. We investigate
the impact of vaccination activities for Haemophilus influenzae type b, hepatitis B, human …

Background Schistosomiasis remains an endemic parasitic disease affecting millions of
people around the world. The World Health Organization (WHO) has set goals of controlling …

Background Considerable efforts have been made to better understand the effectiveness of
large-scale preventive chemotherapy therapy for the control of morbidity caused by infection …

Due to the COVID-19 pandemic, many key neglected tropical disease (NTD) activities have
been postponed. This hindrance comes at a time when the NTDs are progressing towards …

Background Schistosomiasis remains a global-health problem with over 90% of its burden
concentrated in Africa. Field studies reflect the complex ways in which socio-cultural and socio…

Background The 2030 goal for schistosomiasis is elimination as a public health problem (EPHP),
with mass drug administration (MDA) of praziquantel to school-age children (SAC) as a …

Background In line with movement restrictions and physical distancing essential for the control
of the COVID-19 pandemic, WHO recommended postponement of all neglected tropical …

The dynamics of immunity are crucial to understanding the long-term patterns of the SARS-CoV-2
pandemic. Several cases of reinfection with SARS-CoV-2 have been documented 48–…